Stereotactic and Functional Neurosurgery
Pain
Chronic Pain after Spinal Cord Injury: Clinical CharacteristicsRogano L. · Teixeira M.J. · Lepski G.Division of Functional Neurosurgery, Department of Neurology, University of São Paulo Medical School, São Paulo, Brazil
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 29, 2004
Issue release date: January 2004
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3
ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)
For additional information: https://www.karger.com/SFN
Abstract
The clinical characteristics of chronic pain in spinal cord injury patients are controversial. The authors prospectively evaluated 81 patients with chronic pain due to spinal cord lesions. The mean pain intensity according to the visual analogue scale was 9.4. The most common description of pain was a sensation of burning. The initial pain was more severe in patients presenting with myelopathy due to gunshot injuries (p < 0.001). The pain intensity was not associated with the magnitude of the spinal lesion, location of the lesion, occurrence of myofascial pain syndrome or onset of pain. Pain after spinal cord injury was severe, males were more frequently affected and it was more intense when it was the result of gunshot injury. In about 38% of the patients, pharmacological and rehabilitative procedures were effective. Dorsal root entry zone lesion was effective for the treatment of transitional pain in patients with complete section of the spinal cord, spinal cord stimulation was effective for patients with partial lesions of the spinal cord and intrathecal opioid infusion was effective for both conditions.
© 2003 S. Karger AG, Basel
Related Articles:
References
- Demirel G, Yllmaz H, Gençosmanoglu B, Kesiktas N: Pain following spinal cord injury. Spinal Cord 1998;36:25–28.
- Fenollosa P, Palhares J, Cervera J, Pelegrin F, Inigo V, Giner M, Forner V: Chronic pain in the spinal cord injured: Statistical approach and pharmacological treatment. Paraplegia 1993;31:722–729.
- Störmer S, Gerner HJ, Grüninger W, Metzmacher K, Föllinger S, Wienke CH, Aldinger W, Walker N, Zimmermann M, Paeslack V: Chronic pain/dysaesthesiae in spinal cord injury patients: Results of a multicentre study. Spinal Cord 1997;35:446–465.
-
Monks R: Psychotropic drugs; in Wall PD, Melzack R (eds): Textbook of Pain, ed 3. Edinburgh, Churchill Livingstone, 1994, pp 963–989.
- Tasker RR, Decarvalho GTC, Dolan EJ: Intractable pain of spinal cord origin: Clinical features and implications for surgery. J Neurosurg 1992;77:373–378.
-
Hassenbusch SJ, Portenoy RK: Current practices in intraspinal therapy – A survey of clinical trends and decision making. J Pain Sympton Manage 2000;20:S4–S11.
Article / Publication Details
Published online: January 29, 2004
Issue release date: January 2004
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3
ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)
For additional information: https://www.karger.com/SFN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
